Gregory Russotti is Chief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer of Century Therapeutics, Inc. (IPSC). The company reported total compensation of $912,320 for fiscal year 2025.
| Salary | $559,650 |
|---|---|
| Bonus | $0 |
| Stock awards | $71,120 |
| Option awards | $51,240 |
| Non-equity incentive plan | $226,658 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $3,652 |
| Total | $912,320 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Century Therapeutics, Inc. filed April 27, 2026, accession 0001104659-26-049489.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer | $559,650 | $0 | $71,120 | $51,240 | $226,658 | $0 | $3,652 | $912,320 |
| FY2024 | Chief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer | $542,500 | $0 | $127,560 | $547,413 | $256,331 | $0 | $13,800 | $1,487,604 |
Totals as disclosed in each year's own compensation disclosure for Century Therapeutics, Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Chad Cowan | Chief Scientific Officer | $1,167,015 |
| Adrienne Farid | Former Chief Development Officer | $989,403 |
| Gregory Russotti this page | Chief Technology and Manufacturing Officer and former Interim President and Chief Executive Officer | $912,320 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Century Therapeutics, Inc. compensation brief.
Gregory Russotti's compensation sits inside Century Therapeutics, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.